Onderneming Cellular Biomedicine Group, Inc.
Aandelen
CBMG
US15117P1021
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 217
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bi Zuo Liu
CEO | Chief Executive Officer | 60 | 06-02-13 |
Yi Hong Yao
CTO | Chief Tech/Sci/R&D Officer | 57 | 01-08-15 |
Stephan Grupp
PRN | Corporate Officer/Principal | - | - |
Xia Meng
PRN | Corporate Officer/Principal | - | 26-06-17 |
Cheng Xiang Dai
PRN | Corporate Officer/Principal | - | 11-07-13 |
Li Zhang
PRN | Corporate Officer/Principal | - | - |
Andrew Chan
LAW | General Counsel | 66 | 06-02-13 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edward Schafer
BRD | Director/Board Member | 77 | 12-10-19 |
Bi Zuo Liu
CEO | Chief Executive Officer | 60 | 06-02-13 |
Chun Kwok Au
BRD | Director/Board Member | 51 | 11-11-14 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 20 533 547 | 9 058 540 ( 44,12 %) | 1 055 499 ( 5,140 %) | 44,12 % |
Bedrijfsgegevens
AbelZeta Pharma, Inc.
9605 Medical Center Drive Suite 100
20850, Rockville
+240 552 5870
http://www.cellbiomedgroup.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,38% | 39,1 mld. | |
-7,52% | 38,76 mld. | |
+27,67% | 31,24 mld. | |
+12,82% | 25,9 mld. | |
-13,75% | 25,8 mld. | |
+45,88% | 14,06 mld. | |
+40,86% | 13,12 mld. | |
-6,18% | 11,32 mld. | |
-11,63% | 10,68 mld. |